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Abstract
Adhesion of blood platelets to fibrillar collagens plays a crucial role in haemostasis. Collagen type II is a homotrimeric member of the
fibrillar collagen family, whose ability to interact with platelets has been poorly investigated. In this work, we analysed platelet adhesion to
the whole collagen type II molecule, as well as to its CNBr peptides. We found that collagen type II is as efficient as collagen type I in
supporting platelet adhesion. Platelet binding sites on collagen type II were identified in two different CNBr-derived peptides, CB8 and
CB11. The ability of these peptides to support platelet adhesion required the triple helical conformation. Interaction of platelets with CB8 and
CB11 peptides was totally dependent on the presence of Mg2 + ions, and was completely inhibited by the anti-integrin a2h1 antibody P1E6.
Upon adhesion to CB8 and CB11, a significant increase in intracellular protein tyrosine phosphorylation was observed. The pattern of
tyrosine phosphorylated proteins in CB8- and CB11-adherent platelets was very similar to that observed in platelets adherent to the whole
collagen molecule. By immunoprecipitation experiments, we identified two substrates that were tyrosine phosphorylated in adherent platelets
as the tyrosine kinase Syk and the PLCg2 isozyme. By contrast, platelet adhesion to CB8 and CB11 did not promote tyrosine
phosphorylation of FcR g-chain. Finally, we found that collagen type II, but not the CNBr-derived peptides, was able to induce cell
aggregation associated to protein tyrosine phosphorylation when added to a platelet suspension. These results identify the CNBr peptides
from collagen type II CB8 and CB11 as ligands for platelet integrin a2h1, and recognise their ability to support platelet adhesion and
activation.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Platelet interaction with collagen is essential in haemo-
stasis, as it mediates initial recruitment of platelets at the site
of vessel wall injury and initiates platelet activation. Alter-
ation of this interaction is either associated with bleeding
experience or represents a recognised risk factor for stroke
and heart attack [1]. Because of these implications, platelet–
collagen interaction has been deeply investigated in order to
identify the involved platelet receptors and to characterise
the collagen binding sites.
The first receptor described to interact with collagen is
the integrin a2h1. Patients with reduced levels of either a2
or h1 subunits show defective adhesion to collagen [2].
Moreover, antibodies against integrin a2h1 are able to alter
the dose–response curve to collagen although they are
unable to completely block platelet activation when high
concentrations of collagen are used [3,4].
More recently, patients with defective expression of
glycoprotein VI (GPVI) and mild bleeding time prolonga-
tion have been described [5]. GPVI has been recognised as a
second platelet receptor for collagen, and it has been
recently cloned [6]. It is a member of the IgG superfamily
of proteins, and it is constitutively associated with FcR g-
chain. GPVI is mainly involved in platelet activation
induced by collagen [1,7]. A two-state model, in which
integrin a2h1 is responsible for the initial collagen binding
to platelets, while GPVI is involved in the subsequent
platelet activation, has been proposed [8].
Binding sites on the collagen molecule for both platelet
receptors have been identified. GPVI was shown to be
0167-4889/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserved.
doi:10.1016/S0167-4889(02)00401-9
* Corresponding author. Tel.: +39-382-507238; fax: +39-382-507240.
E-mail address: mtorti@unipv.it (M. Torti).
www.bba-direct.com
Biochimica et Biophysica Acta 1640 (2003) 43–51
able to interact with a collagen-related peptide (CRP),
consisting of the repetition of the triplet GPO (Gly–
Pro–Hyp) [7]. When chemically cross-linked, this peptide
is able to activate platelets in an integrin a2h1-independent
manner [9]. Investigation of the integrin a2h1 binding site
on collagen has been performed by using peptides with
natural sequence obtained by digestion of collagen type I
and collagen type III with CNBr. It was shown that
platelet integrin a2h1 is able to recognise sequences
contained in CNBr-derived peptides a1(I)CB3 and
a2(I)CB4 from collagen type I [10,11]. Similar studies
demonstrated that the region of collagen type III able to
interact with integrin a2h1 is located in the peptide
a1(III)CB4, which shares high sequence homology with
a1(I)CB3 [12]. Subsequently, the integrin a2h1 binding
site, located in the CNBr-derived peptide a1(I)CB3, has
been precisely identified as the six amino acid sequence
GFOGER [13].
Although collagen type I and collagen type III have
been extensively used to investigate platelet interaction
with this adhesive class of molecules, very little informa-
tion is available about the interaction of platelets with
another member of the family of fibrillar collagens: colla-
gen type II. Unlike type I, collagen type II is a homotri-
meric molecule composed of three identical a1(II) chains.
In the adult, collagen type II is mainly expressed in the
cartilage and in the vitreous body, and poorly present in
the subendothelial matrix. However, it is temporarily
expressed in a greater number of tissues during embryo-
genesis [14].
In this study, we have investigated platelet adhesion to
collagen type II and collagen type II-derived CNBr peptides,
and we have identified sequences interacting with integrin
a2h1, comprised in the peptides named CB8 and CB11.
Moreover, we have found that integrin a2h1-mediated
adhesion of platelets to CB8 and CB11 induces the activa-
tion of intracellular tyrosine kinases.
2. Materials and methods
2.1. Materials
Sepharose CL-2B was from Amersham Pharmacia Bio-
tech (Cologno Monzese, Italy). Protein A Sepharose was
purchased from Sigma (Milan, Italy). The bicinchoninic
acid assay kit for protein determination was from Pierce
(Pero, Italy). Polystyrene 24-well dishes and 60-mm-diam-
eter dishes were from Orange Scientific (Milan, Italy). The
anti-integrin a2h1 antibody P1E6 was purchased from
Gibco (Milan, Italy), while the anti-GPIb antibody AK2
was kindly provided by Dr. Patrizia Noris (IRCCS, Policli-
nico S. Matteo, Pavia, Italy). Antibodies anti-Syk, anti-
phospholipase Cg2 (PLCg2), and anti-FcR g-chain were
purchased from Santa Cruz Biotech. (Heidelberg, Ger-
many), and the anti-phosphotyrosine antibody 4D10 was
from Upstate Biotechnology (Lake Place, NY, USA). The
GST fusion protein containing the tandem SH2 domains of
Syk was a gift from Dr. Steve Watson (Department of
Pharmacology University of Oxford, UK). Peroxidase-
labeled secondary antibodies were obtained from Bio-Rad
(Milan, Italy). Collagen types I and II were purified from
bovine tendon and nasal septum, respectively, as described
elsewhere [15].
2.2. Preparation of CNBr-derived peptides from collagen
type II
Collagen was digested with CNBr, and peptides were
purified by gel filtration, ion-exchange, and reverse phase
chromatography as previously described [15]. In this work,
we have used five different CNBr-derived peptides (CB6,
CB8, CB10, CB11, CB12). All of them, except CB6 and
CB12, display a triple helical conformation, as determined
by circular dichroism analysis [15].
2.3. Platelet isolation
Blood was withdrawn from healthy donors, using ACD
as anticoagulant, and centrifuged at 120 g for 10 min to
obtain the platelet rich plasma. Platelets were recovered by
centrifugation at 300 g, resuspended in a small volume
(0.5 ml) of autologous plasma and subjected to gel filtration
on sepharose CL-2B. Elution was performed with HEPES
buffer (10 mM HEPES, 137 mM NaCl, 2.9 mM KCl, 12
mM NaHCO3, pH 7.4). For static adhesion assays, platelet
concentration was adjusted to 0.1109 platelets/ml in
HEPES buffer, containing 2 mM MgCl2, 5.5 mM glucose,
and 1% BSA, unless otherwise stated. For aggregation
studies, platelet suspension was diluted to 0.35 109 plate-
lets/ml with HEPES buffer containing 2 mM MgCl2.
2.4. Platelet adhesion assay
Polystyrene 24-well dishes were coated with collagen
molecules by incubation for 16 h at 4 jC with 250 Al of
0.1 AM collagen type I, collagen type II, or with equimolar
amounts of collagen type II-derived CNBr peptides CB6,
CB8, CB10, CB11, and CB12 in PBS containing of 0.5%
BSA. Molarity has been calculated on the basis of the
concentration of native triple helices. Control dishes were
coated with 0.5% BSA in PBS. Wells were washed three
times with 2 ml of PBS, and then blocked with 250 Al of
5% BSA in PBS for 3 h. After three washes, 0.1 ml of the
platelet suspension (0.1109 platelets/ml) were added to
each well, and incubation was prolonged for 90 min. At
the end of the incubation, nonadherent platelets were
removed, and the wells were washed three times with 2
ml of PBS. Percentage of adhesion was calculated using a
bicinchoninic acid assay to quantify the amount of proteins
contained in each well, as described [16,17]. These
amounts were compared with the amounts of proteins
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contained in additional wells in which a known number of
platelets (2 106, 4 106, 6 106 cells/well) were added,
to allow determination of the percentage of adherent
platelets.
2.5. Immunoprecipitation
For immunoprecipitation experiments, adhesion assays
were performed in 60-mm dishes coated with 1 ml of 0.1
AM collagen type II, CB8, or CB11 peptides in PBS.
Dishes were washed three times with 5 ml of PBS and
blocked with 2 ml of 5% BSA in PBS for 3 h. Aliquots of
the platelet suspension (0.5 ml aliquots of 0.2 109
platelets per milliliter) were added. Upon incubation for
90 min, nonadherent platelets were gently removed and
collected. Dishes were washed three times, and adherent
platelets were lysed with 0.25 ml of ice-cold immunopre-
cipitation buffer (10 mM Tris/HCl pH 7.4, 158 mM NaCl,
1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 5
mM EGTA, 1 mM PMSF, 10 Ag/ml leupeptin, 10 Ag/ml
aprotinin, 1 mM Na3VO4). Nonadherent platelets were also
lysed with 1 volume of immunoprecipitation buffer 2 .
Lysed platelets were kept on ice for 15 min, and then
centrifuged at 13000 rpm for 10 min to remove insoluble
materials. Protein content in the cleared lysates was
determined by bicinchoninic acid assay and then two
aliquots, containing the same amount of proteins, were
prepared from all the samples. One aliquot was immedi-
ately dissociated with SDS-sample buffer (25 mM Tris,
192 mM glycine, 2% SDS, 0.5% DTT, 10% glycerol,
0.01% bromophenol blue, pH 8.3) for immunoblotting
analysis of the whole cell lysates, while the other aliquot
was precleared with 100 Al of protein A sepharose (50 mg/
ml) for 1 h at 4 jC, and used for immunoprecipitation. The
cleared lysates were incubated for 2 h at 4 jC with 1 Ag of
anti-Syk or anti-PLCg2 antisera. The immunocomplexes
were collected by addition of 100 Al of protein A-Sephar-
ose and incubation for 45 min, and washed three times
with 1 ml of ice-cold immunoprecipitation buffer. The
pellets were resuspended with 25 Al of SDS sample buffer
and heated at 95 jC for 3 min. Tyrosine phosphorylation
of FcR g-chain was evaluated essentially as described by
Gibbins et al. [18], using a precipitation assay with a GST
fusion protein containing the tandem SH2 domains of Syk.
Precipitated proteins were separated by SDS-PAGE on
10–20% acrylamide gels and analysed by immunoblotting
with anti-FcR g-chain antibody.
2.6. Immunoblotting
Both whole platelet samples and immunoprecipitates
were subjected to SDS-PAGE on 7.5% or 10–20% acryl-
amide gels. Proteins were transferred to nitrocellulose
membranes and tested with antibodies against phosphotyr-
osine, Syk, PLCg2, or FcR g-chain as previously described
[19].
3. Results
3.1. Platelet adhesion to collagen type II and to collagen
type II CNBr peptides
Gel-filtered platelets were added to 24-well plates coated
with BSA, collagen type I, collagen type II, or five different
peptides obtained by digestion of collagen type II with
CNBr (CB10, CB11, CB8, CB12, CB6). Adhesion assays
were performed for 90 min in the presence of 2 mM MgCl2.
Nonadherent platelets were then removed and the percent-
age of adherent platelets was evaluated by the bicinchoninic
acid assay as described in Materials and methods. Fig. 1A
shows that collagen type II was able to promote a significant
platelet adhesion (53.34F 3.77%), which was very similar
to that promoted by collagen type I. In control wells,
nonspecific adhesion to BSA was lower than 10%. Among
Fig. 1. Platelet adhesion to collagen type II and collagen type II-derived
CNBr peptides. (A) Equimolar amounts of BSA, collagen type I (coll I),
collagen type II (coll II), and five different CNBr peptides derived from
collagen type II (CB10, CB11, CB8, CB12, CB6) were immobilised on 24-
well plates at 4 jC to preserve the triple helical conformation. Gel-filtered
platelets (100 Al, 108 platelets/ml) were incubated with immobilised
molecules for 90 min in the presence of 2 mM MgCl2. Adherent platelets
were then collected, and the percentage of platelet adhesion was calculated
by determining the total protein content, as described in Materials and
methods. Results are the meanF S.D. of three to six different experiments.
(B) Collagen type II (coll) and CNBr peptides CB8 and CB11 were
denatured by incubation at 60 jC for 5 min. Both native (filled bars) and
denatured (open bars) molecules were immobilised on 24-well plates at 37
jC to prevent renaturation, and then incubated with gel-filtered platelets
(100 Al, 108 platelets/ml) for 90 min. The percentage of adhesion was
calculated as described in Materials and methods. Results are the
meanF S.D. of three to four experiments.
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the CNBr peptides derived from collagen type II, only CB8
and CB11 were able to promote a significant platelet
adhesion. The percentage of adherent cells to CB8 was
41.23F 4.85%, while platelet adhesion to CB11 was clearly
lower (18.96F 5.24%). By contrast, platelet adhesion to
immobilised CB10, CB12, and CB6 was comparable to the
nonspecific binding to BSA-coated wells.
We next investigated the importance of the triple helical
configuration of the whole collagen molecule and peptides
for interaction with platelets. CB8, CB11, and collagen type
II were heated for 5 min at 60 jC to induce denaturation.
Coating of polystyrene plates with denatured molecules was
performed for 16 h at 37 jC to prevent protein renaturation.
Fig. 1B shows a strongly reduced platelet adhesion to the
denatured molecules, indicating that the triple helical con-
figuration plays an important role for interaction with these
cells. The reduction of platelet adhesion to denatured CB8
and CB11 was more evident than the inhibition of platelet
adhesion to denatured collagen molecule. This indicates that
collagen, but not CNBr peptides, partially maintains binding
sites for platelets after denaturation.
3.2. Interaction of platelets with peptides CB8 and CB11 is
Mg2+-dependent and is supported by integrin a2b1
Platelets adhesion to collagen has been shown to require
Mg2 + and to be at least partially mediated by integrin a2h1
[20]. Therefore, we investigated the effect of Mg2 + on
platelet adhesion to CNBr peptides CB8 and CB11. As
shown in Fig. 2, platelet adhesion to both CB8 and CB11
was completely abolished in the presence of the chelator
EDTA, indicating that Mg2 + is essential for this interaction.
To investigate the role of integrin a2h1 on platelet
interaction with peptides CB8 and CB11, adhesion assays
were performed using platelets preincubated with either an
antibody against integrin a2h1 (P1E6 clone) or an antibody
against GPIb (AK2 clone) as negative control. Both P1E6
and AK2 are known to block target receptor activity [21,22].
Fig. 2 shows that specific platelet adhesion to CB8 and
CB11 was completely inhibited by P1E6. By contrast,
platelet adhesion to both peptides was not inhibited in the
presence of the anti GPIb antibody AK2. These results
indicate that platelets bind to CB8 and CB11 through
integrin a2h1. In similar adhesion assays, we found that
platelet interaction with type II collagen whole molecule
was decreased, but not completely blocked, in the presence
of P1E6 (Fig. 2), indicating that additional collagen recep-
tors, such as GPVI, are involved in binding the whole
collagen molecule, but not CNBr peptides.
3.3. Platelet adhesion to CB8 and CB11 induces protein
tyrosine phosphorylation
It is known that platelet adhesion to collagen type I
induces the activation of intracellular tyrosine kinases [23].
Therefore, we investigated the level of protein tyrosine
phosphorylation in platelet adherent to both collagen type
II and CNBr peptides CB8 and CB11. Polystyrene dishes
were coated with equimolar amounts of collagen type II,
CB8, and CB11 peptides, and incubated with gel-filtered
platelets for 90 min in the presence of 2 mM MgCl2. Both
nonadherent and adherent platelets were recovered and
lysed with an equal volume of immunoprecipitation buffer
2 . In parallel, a sample containing 108 platelets was also
lysed with immunoprecipitation buffer 2 . The protein
content of lysed samples were determined by the bicincho-
ninic acid assay and aliquots of total, nonadherent, and
adherent platelets containing the same amount of proteins
were separated by SDS-PAGE on a 7.5% gel and analysed
by immunoblotting with anti-phosphotyrosine antibody. A
single band of about of 60 kDa, probably corresponding to
the tyrosine kinase pp60src, was detected in samples of total
platelets and nonadherent platelets (Fig. 3). However, a
remarkable increase in the number of tyrosine phosphory-
lated proteins was observed in platelets adherent to collagen
type II, CB8, and CB11. Although tyrosine phosphorylated
bands with comparable apparent molecular masses (about
150, 120, 100, 80, and 74 kDa) were revealed in platelets
adherent to all the three molecules analysed, the reactivity to
anti-phosphotyrosine antibody was similar in cells interact-
ing with the whole collagen molecule and CB8 peptide, but
weaker in cell adherent to CB11. Protein tyrosine phosphor-
ylation in platelets adherent to collagen, CB8, and CB11
was not affected by the presence of apyrase or by the
preincubation with aspirin (data not shown), indicating that
this event was directly promoted by recruitment of integrin
a2h1 and did not involve the action of released molecules
such as ADP or thromboxane A2.
Although platelet adhesion to CB8 and CB11 appears to
be mediated by integrin a2h1, we evaluated the possible
Fig. 2. Adhesion of platelets to CB8 and CB11 peptides is mediated by
integrin a2h1. Gel-filtered platelets were incubated with immobilised
peptides CB8 and CB11 or with immobilised collagen type II for 90 min in
the presence of 2 mM MgCl2, 2 mM EDTA, 2 mM MgCl2 and anti integrin
a2h1 ascitic fluid (P1E6) 1:500 diluted, or 2 mM MgCl2 and anti-GPIb
ascitic fluid (AK2) 1:500 diluted, as indicated. Platelet adhesion was
evaluated by using the bicinchoninic acid assay. Results are the
meanF S.D. of three to six different experiments.
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contribution of GPVI to adhesion-dependent protein tyro-
sine phosphorylation. The activation of GPVI was measured
by evaluating the tyrosine phosphorylation of associated
FcR g-chain. This was performed by using a pull-down
assay using the tandem SH2 domains of Syk expressed as a
GST fusion protein (GST-Syk SH2) to selectively precip-
itate the phosphorylated form of FcR g-chain from a platelet
lysate, as previously described [18]. In preliminary experi-
ments, we confirmed, that, in our experimental conditions,
stimulation of a platelet suspension with collagen, but not
with thrombin, induced the tyrosine phosphorylation of FcR
g-chain and its association with GST-Syk SH2 (Fig. 4A).
Fig. 4B shows that the GST-Syk SH2 was able to precipitate
FcR g-chain from collagen-adherent platelets, but not from
platelets adherent to CB8 or CB11. Parallel analysis of
aliquots of total cell lysate revealed that comparable
amounts of FcR g-chain were present in all the samples.
These results indicate that activation of GPVI may occur
upon platelet adhesion to collagen but not upon adhesion to
CB8 and CB11 peptides.
We next tried to identify some of the tyrosine phosphory-
lated proteins in platelets adherent to collagen type II, CB8,
and CB11. We focused our attention on the tyrosine kinase
Syk and on the PLCg2 isozyme, which are known to play a
crucial role in platelet activation by collagen [24,25]. After
incubation with immobilised collagen, CB8, or CB11,
adherent and nonadherent platelets were lysed with immu-
noprecipitation buffer. Syk and PLCg2 were immunopreci-
pitated with specific antibodies and were tested by
immunoblotting with anti-phosphotyrosine antibody. As
shown in Fig. 5A, Syk was strongly tyrosine phosphorylated
Fig. 4. Analysis of FcR g-chain tyrosine phosphorylation in platelet adherent
to collagen, CB8, and CB11. (A) Gel-filtered platelets were stimulated in
suspension with 100 Ag/ml collagen or with 1 U/ml thrombin for 1 min at 37
jC, and then lysed with immunoprecipitation buffer. The phosphorylated
form of FcR g-chain was precipitated with 10 Ag of GST-Syk SH2, separated
by SDS-PAGE on a 10–20% acrylamide gel, transferred to nitrocellulose,
and revealed by immunoblotting with anti-FcR g-chain (upper panel). In
parallel, aliquots (20 Al) of whole cell lysates (WCL) were probed by
immunoblotting with the anti-FcR g-chain (lower panel). (B) Platelets
adherent to collagen, CB8, and CB11 peptides were lysed with
immunoprecipitation buffer. An aliquot of WCL was directly probed by
immunoblotting with the anti-FcR g-chain to compare the total amount of
the protein in the different samples (lower panel). The remaining of the
samples were precipitated with 10 Ag of GST-Syk SH2, and the presence of
the phosphorylated form of FcR g-chain in the precipitated proteins was
evaluated by immunoblotting with a specific antibody (upper panel).
Fig. 5. Tyrosine phosphorylation of Syk and PLCg2 in collagen-, CB8-, and
CB11-adherent platelets. Platelet adhesion assays to immobilised collagen
type II, CB8, and CB11 peptides were performed in 60-mm dishes in the
presence of 2 mM MgCl2. Adherent and nonadherent platelets were lysed
with immunoprecipitation buffer, and aliquots containing the same amount
of proteins were used for immunoprecipitation of Syk (A) and PLCg2 (B).
Immunoprecipitates were dissociated with SDS sample buffer, separated by
SDS-PAGE, and transferred to nitrocellulose. Filters were tested with
antibody anti-phosphotyrosine (upper panels), and subsequently reprobed
with either anti-Syk or anti-PLCg2 (lower panels) as indicated on the right.
Fig. 3. Protein tyrosine phosphorylation in collagen type II-, CB8-, and
CB11-adherent platelets. Equimolar amounts of collagen type II, CB8, and
CB11 (1 ml, 0.1 AM) were immobilised on polystyrene 60-mm dishes and
then incubated with gel-filtered platelets. After 90 min, samples of total
platelets (Tot), nonadherent platelets (NA), and adherent platelets (A) were
collected and lysed with immunoprecipitation buffer. The protein content
was determined, and aliquots containing the same amount of proteins were
separated by SDS-PAGE on a 7.5% acrylamide gel, and then analysed by
immunoblotting with anti-phosphotyrosine antibody. The positions of
standard molecular mass markers are reported on the left.
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in platelets adherent to collagen, CB8, and even to CB11,
but not in nonadherent platelets. Reprobing of the same
nitrocellulose with anti Syk antibody showed that the
protein was similarly immunoprecipitated from all the
analysed samples. Moreover, Fig. 5B shows that PLCg2
was also tyrosine phosphorylated in platelets adherent to
immobilised collagen or peptides, while no phosphorylation
of PLCg2 was detected in nonadherent platelets. Subsequent
analysis with anti-PLCg2 antibody showed that the enzyme
was actually precipitated from all the samples.
3.4. Whole collagen type II, but not CNBr peptides, is able
to activate platelets in suspension
Although collagen plays a major role in platelet adhesion
to the subendothelial matrix, it is very well known that it can
induce activation and aggregation when added to a suspen-
sion of gel-filtered or washed platelets [3,5,25]. Fig. 6A
shows that collagen type II can also rapidly induce platelet
aggregation with a potency very similar to that of thrombin.
Since we have found that the CNBr peptides derived from
collagen type II, CB8, and CB11 are able to support
activation of adherent platelets, we investigated whether
they also display, like the whole collagen molecule, the
ability to stimulate platelets in suspension. Fig. 6A shows
that in contrast to collagen, neither CB8 nor CB11 are able
to induce aggregation of gel-filtered platelets. Even when
both peptides were added simultaneously to a platelet
suspension, aggregation was not observed.
We next compared the ability of soluble CB8, CB11, and
of the whole collagen type II to induce protein tyrosine
phosphorylation in a platelet suspension. Fig. 6B shows that
collagen type I and collagen type II induced a very similar
increase of tyrosine phosphorylated proteins when added to
a platelet suspension. By contrast, when CB8 and CB11,
alone or in combination, were added to a platelet suspen-
sion, no significant increase in protein tyrosine phosphor-
ylation was observed. These results indicate that, in contrast
to the whole collagen molecule, CNBr peptides support
platelet activation exclusively when immobilised on a
plastic surface.
4. Discussion
In this work, we have investigated the interaction of
human platelets with collagen type II, a member of the
family of fibrillar collagen as collagen types I and III.
Collagen type II is the major component of cartilage in
adults, but it is widely distributed during fetal life, and it is
also abundant in the vitreous body [14]. To identify the
platelet-binding sites on collagen type II, we compared
platelet adhesion to the whole molecule with that supported
by CNBr peptides that have stable triple helical conforma-
tion and that represent, together, almost the entire collagen
molecule (Fig. 7). Collagen type II is a homotrimeric
Fig. 6. Effect of collagen type II, CB8, and CB11 peptides on aggregation
and tyrosine phosphorylation of platelets in suspension. (A) Gel-filtered
platelets (500 Al, 0.35 109/ml) were incubated a Chrono Log aggreg-
ometer under constant stirring and then stimulated with 0.6 U/ml thrombin,
10 Ag/ml collagen type II, 10 Ag/ml CB8, or 10 Ag/ml CB11 in the presence
of 2 mM MgCl2. Aggregation was monitored continuously. (B) Platelet
samples were treated with buffer (Bas), 10 Ag/ml collagen type I (Coll I), 10
Ag/ml collagen type II (Coll II), and 10 Ag/ml peptides CB8 and CB11
alone or in combination for 2 min under constant stirring. Samples were
lysed and then analysed by SDS-PAGE on a 7.5% acrylamide gel followed
by immunoblotting with anti-phosphotyrosine antibody.
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molecule, and some of the CNBr peptides are also able to
associate in homotrimers [15]. This makes collagen type II a
more interesting model than collagen type I, which is an
heterotrimer, while its CNBr peptides, previously used in a
number of studies, are homotrimers. In this paper, we have
shown that only two CNBr peptides from collagen type II
are able to support platelet adhesion. One of them, CB8,
encompassing residues 402–550 of the triple helical domain
of a1(II), was found to be very efficient as it was able to
promote the adhesion of about 40% of added platelets. Such
percentage was very similar to that measured to the whole
collagen molecule. The other peptide (CB11, residues 124–
401) was also able to mediate a significant platelet adhesion,
although less efficiently.
Analysis of the peptide sequence revealed that peptide
CB8 contains the GFOGER sequence (residues 502–507),
which is known to represent a binding site for platelets
[13,26]. Moreover, within the collagen molecule, the loca-
tion of CB8 corresponds to the peptides a1(I)CB3 and
a1(III)CB4 (Fig. 7), which have been reported to mediate
platelet adhesion to collagen type I and type III, respectively
[10,12]. CB11 peptide is the equivalent of the peptide
a1(I)CB8 from collagen type I, which is also known to
weakly contribute to platelet adhesion [10]. However, differ-
ently from what has been previously reported in studies
using CNBr-derived peptides from collagen type I [10], we
have demonstrated that CB8 and CB11 peptides from
collagen type II are unable to support platelet adhesion
when heat-denatured to single chains.
We have also demonstrated that platelet interaction with
CB8 and CB11 is totally mediated by integrin a2h1, as it is
completely inhibited in the absence of Mg2 + or in the
presence of an integrin a2h1-specific antibody. Moreover,
we have found that, in contrast to collagen, platelet adhesion
to CB8 and CB11 does not support tyrosine phosphorylation
of FcR g-chain, indicating that GPVI is not activated during
this process. Therefore, this study demonstrates that, unlike
the whole collagen molecule that can bind different recep-
tors on the platelet surface [27], CB8 and CB11 can be
considered specific ligands for integrin a2h1.
Interaction with collagen is known to induce platelet
activation [28]. This process is mainly mediated by the
GPVI receptor on platelet surface [1,8]. However, a body of
evidence suggests that integrin a2h1 is also involved in
collagen-induced platelet activation [29,30]. Since the
whole collagen molecule binds both GPVI and integrin
a2h1, it may not represent the most suitable tool to inves-
tigate the involvement of integrin a2h1 in platelet activation.
In this context, the identification of CB8 and CB11 peptides
from collagen type II as specific ligands for integrin a2h1
may define new tools to investigate the role of this integrin
receptor on platelet activation. Although CNBr-derived
peptides from collagen type I have been used in previous
studies to identify binding sites for platelets on the collagen
molecule, the ability of these natural peptides to support
platelet activation has not been deeply investigated. In this
study, we have shown that a significant tyrosine phosphor-
ylation of several proteins occurred after adhesion of plate-
lets to both collagen type II, CB8 and CB11. Since
interaction of platelets with CB8 and CB11 is mediated by
integrin a2h1, these results indicate that the integrin receptor
is actually able to induce activation of tyrosine kinases. The
pattern of protein tyrosine phosphorylation is similar in
platelets adherent both to collagen and CB8 or CB11,
suggesting that integrin a2h1 significantly contributes to
this process when the whole collagen molecule is used.
Immunoprecipitation studies revealed that two important
signalling proteins, such as Syk and PLCg2, become tyro-
sine phosphorylated upon platelet interaction with both
peptides.
In this work, we have also found that, unlike the whole
collagen molecule, neither CB8 nor CB11 is able to stim-
Fig. 7. Scheme of CNBr peptides from type I, type II, and type III a1 domains. The scheme shows the name and the position along the triple helical domain of
collagen type II of the peptides used in this work (first lane). The name and the position of homologous peptides in a1(I) chain (second lane) and in a1(III)
chain (third lane) that are known to mediate platelet adhesion are also shown.
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ulate protein tyrosine phosphorylation when added to a
platelet suspension. Moreover, we have found that these
CNBr peptides do not promote platelet aggregation. This
indicates that immobilisation on a plastic surface is abso-
lutely required for CNBr peptides to induce platelet activa-
tion. By contrast, the whole collagen type II molecule is
equally efficient in promoting activation of both adherent
platelets and platelets in suspension. The different behaviour
of collagen type II and CB8 and CB11 may reflect the fact
that while the whole collagen molecule may rapidly organ-
ise itself into fibrils, CB8 and CB11 peptides are not able to
form fibrils. Collagen-induced platelet activation seems to
require a multimeric ligand able to induce oligomerisation
of membrane receptors, including integrin a2h1 [31]. In
suspension, this may be achieved by fibrillar collagen but
not by nonfibrillar peptides. However, immobilisation of
peptides on a plastic surface may generate a random net-
work of ligands that can induce oligomerisation of recruited
integrin a2h1, leading to platelet activation.
In conclusion, our results indicate that integrin a2h1 is
sufficient to mediate interaction with CNBr peptides from
collagen type II. Moreover, the stimulation of tyrosine
kinases as a consequence of this interaction confirms a
significant role of integrin a2h1 in the activation of colla-
gen-adherent platelets.
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